# Destination XL Group, Inc.: financial statements, quarterly

DXLG · Nasdaq · CIK 813298 · [Consumer discretionary](/sectors/consumer-discretionary.md) · fiscal year ends Jan 31

Pages: [Overview](/companies/dxlg.md) · [Financials](/companies/dxlg/financials.md) · [Filings](/companies/dxlg/filings.md) · [Insiders](/companies/dxlg/insiders.md)

Standardized line items from XBRL company facts. Each value links to its filing; d marks a value derived from year-to-date figures. Other view: [annual](/companies/dxlg/financials.md?period=annual).

## Income statement

| Line item | Unit | Q3 FY2023 (2023-10-28) | Q4 FY2023 (2024-02-03) | Q1 FY2024 (2024-05-04) | Q2 FY2024 (2024-08-03) | Q3 FY2024 (2024-11-02) | Q4 FY2024 (2025-02-01) | Q1 FY2025 (2025-05-03) | Q2 FY2025 (2025-08-02) | Q3 FY2025 (2025-11-01) | Q4 FY2025 (2026-01-31) | Q1 FY2026 (2026-05-02) | Q2 FY2026 (2026-08-01) |
| --- | --- | ---: | ---: | ---: | ---: | ---: | ---: | ---: | ---: | ---: | ---: | ---: | ---: |
| Revenue | $m | [119](/filings/0000950170-24-130111.md) | [137 d](/filings/0001193125-26-115660.md) | [115](/filings/0000950170-25-078693.md) | [125](/filings/0001193125-25-189456.md) | [108](/filings/0001193125-25-316166.md) | [119 d](/filings/0001193125-26-115660.md) | [106](/filings/0001193125-26-255525.md) | [116](/filings/0001193125-26-386417.md) | [102](/filings/0001193125-25-316166.md) | [112 d](/filings/0001193125-26-115660.md) | [103](/filings/0001193125-26-255525.md) | [112](/filings/0001193125-26-386417.md) |
| Cost of revenue | $m | [62.6](/filings/0000950170-24-130111.md) | [72.6 d](/filings/0001193125-26-115660.md) | [59.8](/filings/0000950170-25-078693.md) | [64.6](/filings/0001193125-25-189456.md) | [59.1](/filings/0001193125-25-316166.md) | [66.3 d](/filings/0001193125-26-115660.md) | [58.0](/filings/0001193125-26-255525.md) | [63.3](/filings/0001193125-26-386417.md) | [58.3](/filings/0001193125-25-316166.md) | [66.4 d](/filings/0001193125-26-115660.md) | [57.6](/filings/0001193125-26-255525.md) | [58.1](/filings/0001193125-26-386417.md) |
| Gross profit | $m | [56.6](/filings/0000950170-24-130111.md) | [64.5 d](/filings/0001193125-26-115660.md) | [55.7](/filings/0000950170-25-078693.md) | [60.2](/filings/0001193125-25-189456.md) | [48.4](/filings/0001193125-25-316166.md) | [52.9 d](/filings/0001193125-26-115660.md) | [47.6](/filings/0001193125-26-255525.md) | [52.2](/filings/0001193125-26-386417.md) | [43.5](/filings/0001193125-25-316166.md) | [45.7 d](/filings/0001193125-26-115660.md) | [45.8](/filings/0001193125-26-255525.md) | [53.4](/filings/0001193125-26-386417.md) |
| Selling, general and administrative | $m | [48.0](/filings/0000950170-24-130111.md) | [52.8 d](/filings/0001193125-26-115660.md) | [47.5](/filings/0000950170-25-078693.md) | [53.7](/filings/0001193125-25-189456.md) | [47.4](/filings/0001193125-25-316166.md) | [49.7 d](/filings/0001193125-26-115660.md) | [47.4](/filings/0001193125-26-255525.md) | [47.5](/filings/0001193125-26-386417.md) | [45.5](/filings/0001193125-25-316166.md) | [46.8 d](/filings/0001193125-26-115660.md) | [46.5](/filings/0001193125-26-255525.md) | [45.7](/filings/0001193125-26-386417.md) |
| Operating income | $m | [5.3](/filings/0000950170-24-130111.md) | [8.1 d](/filings/0001193125-26-115660.md) | [4.9](/filings/0000950170-25-078693.md) | [3.1](/filings/0001193125-25-189456.md) | [(2.5)](/filings/0001193125-25-316166.md) | [(1.7) d](/filings/0001193125-26-115660.md) | [(3.5)](/filings/0001193125-26-255525.md) | [0.7](/filings/0001193125-26-386417.md) | [(5.7)](/filings/0001193125-25-316166.md) | [(9.6) d](/filings/0001193125-26-115660.md) | [(5.9)](/filings/0001193125-26-255525.md) | [1.9](/filings/0001193125-26-386417.md) |
| Income tax | $m | [1.7](/filings/0000950170-24-130111.md) | [2.1 d](/filings/0001193125-26-115660.md) | [1.7](/filings/0000950170-25-078693.md) | [1.3](/filings/0001193125-25-189456.md) | [(0.2)](/filings/0001193125-25-316166.md) | [(0.0) d](/filings/0001193125-26-115660.md) | [(1.3)](/filings/0001193125-26-255525.md) | [1.2](/filings/0001193125-26-386417.md) | [(1.5)](/filings/0001193125-25-316166.md) | [20.1 d](/filings/0001193125-26-115660.md) | [0.1](/filings/0001193125-26-255525.md) | [(0.0)](/filings/0001193125-26-386417.md) |
| Net income | $m | [4.0](/filings/0000950170-24-130111.md) | [5.2 d](/filings/0001193125-26-239304.md) | [3.8](/filings/0001193125-25-316166.md) | [2.4](/filings/0001193125-25-316166.md) | [(1.8)](/filings/0001193125-25-316166.md) | [(1.3) d](/filings/0001193125-26-239304.md) | [(1.9)](/filings/0001193125-26-386417.md) | [(0.3)](/filings/0001193125-26-386417.md) | [(4.1)](/filings/0001193125-25-316166.md) | [(29.6) d](/filings/0001193125-26-239304.md) | [(5.9)](/filings/0001193125-26-386417.md) | [2.0](/filings/0001193125-26-386417.md) |
| Diluted EPS | $ per share | [0.06](/filings/0000950170-24-130111.md) | not reported | [0.06](/filings/0000950170-25-078693.md) | [0.04](/filings/0001193125-25-189456.md) | [(0.03)](/filings/0001193125-25-316166.md) | not reported | [(0.04)](/filings/0001193125-26-255525.md) | [0.00](/filings/0001193125-26-386417.md) | [(0.08)](/filings/0001193125-25-316166.md) | not reported | [(0.11)](/filings/0001193125-26-255525.md) | [0.04](/filings/0001193125-26-386417.md) |
| Basic EPS | $ per share | [0.07](/filings/0000950170-24-130111.md) | not reported | [0.07](/filings/0000950170-25-078693.md) | [0.04](/filings/0001193125-25-189456.md) | [(0.03)](/filings/0001193125-25-316166.md) | not reported | [(0.04)](/filings/0001193125-26-255525.md) | [0.00](/filings/0001193125-26-386417.md) | [(0.08)](/filings/0001193125-25-316166.md) | not reported | [(0.11)](/filings/0001193125-26-255525.md) | [0.04](/filings/0001193125-26-386417.md) |

- Revenue: us-gaap:RevenueFromContractWithCustomerExcludingAssessedTax
- Cost of revenue: us-gaap:CostOfGoodsAndServicesSold
- Gross profit: us-gaap:GrossProfit
- Selling, general and administrative: us-gaap:SellingGeneralAndAdministrativeExpense
- Operating income: us-gaap:OperatingIncomeLoss
- Income tax: us-gaap:IncomeTaxExpenseBenefit
- Net income: us-gaap:NetIncomeLoss
- Diluted EPS: us-gaap:EarningsPerShareDiluted
- Basic EPS: us-gaap:EarningsPerShareBasic

## Balance sheet

| Line item | Unit | Q3 FY2023 (2023-10-28) | FY2023 (2024-02-03) | Q1 FY2024 (2024-05-04) | Q2 FY2024 (2024-08-03) | Q3 FY2024 (2024-11-02) | FY2024 (2025-02-01) | Q1 FY2025 (2025-05-03) | Q2 FY2025 (2025-08-02) | Q3 FY2025 (2025-11-01) | FY2025 (2026-01-31) | Q1 FY2026 (2026-05-02) | Q2 FY2026 (2026-08-01) |
| --- | --- | ---: | ---: | ---: | ---: | ---: | ---: | ---: | ---: | ---: | ---: | ---: | ---: |
| Cash and equivalents | $m | [10.7](/filings/0000950170-23-064680.md) | [27.6](/filings/0000950170-25-042703.md) | [16.3](/filings/0000950170-24-066390.md) | [21.5](/filings/0000950170-24-101685.md) | [7.1](/filings/0000950170-24-130111.md) | [11.9](/filings/0001193125-26-115660.md) | [8.1](/filings/0000950170-25-078693.md) | [14.0](/filings/0001193125-25-189456.md) | [14.6](/filings/0001193125-25-316166.md) | [23.8](/filings/0001193125-26-386417.md) | [11.1](/filings/0001193125-26-255525.md) | [17.0](/filings/0001193125-26-386417.md) |
| Current assets | $m | [171](/filings/0000950170-23-064680.md) | [153](/filings/0000950170-25-042703.md) | [155](/filings/0000950170-24-066390.md) | [152](/filings/0000950170-24-101685.md) | [140](/filings/0000950170-24-130111.md) | [132](/filings/0001193125-26-115660.md) | [125](/filings/0000950170-25-078693.md) | [123](/filings/0001193125-25-189456.md) | [121](/filings/0001193125-25-316166.md) | [111](/filings/0001193125-26-386417.md) | [109](/filings/0001193125-26-255525.md) | [106](/filings/0001193125-26-386417.md) |
| Total assets | $m | [373](/filings/0000950170-23-064680.md) | [358](/filings/0000950170-25-042703.md) | [377](/filings/0000950170-24-066390.md) | [384](/filings/0000950170-24-101685.md) | [381](/filings/0000950170-24-130111.md) | [381](/filings/0001193125-26-115660.md) | [380](/filings/0000950170-25-078693.md) | [409](/filings/0001193125-25-189456.md) | [402](/filings/0001193125-25-316166.md) | [367](/filings/0001193125-26-386417.md) | [366](/filings/0001193125-26-255525.md) | [356](/filings/0001193125-26-386417.md) |
| Current liabilities | $m | [101](/filings/0000950170-23-064680.md) | [89.9](/filings/0000950170-25-042703.md) | [87.0](/filings/0000950170-24-066390.md) | [83.2](/filings/0000950170-24-101685.md) | [89.6](/filings/0000950170-24-130111.md) | [90.7](/filings/0001193125-26-115660.md) | [86.2](/filings/0000950170-25-078693.md) | [81.6](/filings/0001193125-25-189456.md) | [85.3](/filings/0001193125-25-316166.md) | [85.5](/filings/0001193125-26-386417.md) | [86.6](/filings/0001193125-26-255525.md) | [80.9](/filings/0001193125-26-386417.md) |
| Total liabilities | $m | not reported | not reported | not reported | not reported | not reported | not reported | not reported | not reported | not reported | not reported | not reported | not reported |
| Long-term debt | $m | not reported | not reported | not reported | not reported | not reported | not reported | not reported | not reported | not reported | not reported | not reported | not reported |
| Current portion of debt | $m | not reported | not reported | not reported | not reported | not reported | not reported | not reported | not reported | not reported | not reported | not reported | not reported |
| Short-term borrowings | $m | not reported | not reported | not reported | not reported | not reported | not reported | not reported | not reported | not reported | not reported | not reported | not reported |
| Shareholders' equity | $m | [151](/filings/0000950170-24-130111.md) | [149](/filings/0001193125-26-115660.md) | [154](/filings/0001193125-25-316166.md) | [157](/filings/0001193125-25-316166.md) | [145](/filings/0001193125-25-316166.md) | [141](/filings/0001193125-26-386417.md) | [141](/filings/0001193125-26-386417.md) | [141](/filings/0001193125-26-386417.md) | [137](/filings/0001193125-25-316166.md) | [108](/filings/0001193125-26-386417.md) | [103](/filings/0001193125-26-386417.md) | [105](/filings/0001193125-26-386417.md) |

- Cash and equivalents: us-gaap:CashAndCashEquivalentsAtCarryingValue
- Current assets: us-gaap:AssetsCurrent
- Total assets: us-gaap:Assets
- Current liabilities: us-gaap:LiabilitiesCurrent
- Total liabilities: not reported
- Long-term debt: not reported
- Current portion of debt: not reported
- Short-term borrowings: not reported
- Shareholders' equity: us-gaap:StockholdersEquity

## Cash flow

| Line item | Unit | Q3 FY2023 (2023-10-28) | Q4 FY2023 (2024-02-03) | Q1 FY2024 (2024-05-04) | Q2 FY2024 (2024-08-03) | Q3 FY2024 (2024-11-02) | Q4 FY2024 (2025-02-01) | Q1 FY2025 (2025-05-03) | Q2 FY2025 (2025-08-02) | Q3 FY2025 (2025-11-01) | Q4 FY2025 (2026-01-31) | Q1 FY2026 (2026-05-02) | Q2 FY2026 (2026-08-01) |
| --- | --- | ---: | ---: | ---: | ---: | ---: | ---: | ---: | ---: | ---: | ---: | ---: | ---: |
| Operating cash flow | $m | [6.9 d](/filings/0000950170-24-130111.md) | [16.5 d](/filings/0001193125-26-115660.md) | [(1.1)](/filings/0000950170-25-078693.md) | [17.1 d](/filings/0001193125-25-189456.md) | [(3.5) d](/filings/0001193125-25-316166.md) | [17.1 d](/filings/0001193125-26-115660.md) | [(12.0)](/filings/0001193125-26-255525.md) | [9.9 d](/filings/0001193125-26-386417.md) | [(1.1) d](/filings/0001193125-25-316166.md) | [5.3 d](/filings/0001193125-26-115660.md) | [(8.8)](/filings/0001193125-26-255525.md) | [6.0 d](/filings/0001193125-26-386417.md) |
| Capital expenditure | $m | [5.7 d](/filings/0000950170-24-130111.md) | [7.0 d](/filings/0001193125-26-115660.md) | [5.9](/filings/0000950170-25-078693.md) | [6.9 d](/filings/0001193125-25-189456.md) | [6.6 d](/filings/0001193125-25-316166.md) | [8.3 d](/filings/0001193125-26-115660.md) | [6.7](/filings/0001193125-26-255525.md) | [5.4 d](/filings/0001193125-26-386417.md) | [4.9 d](/filings/0001193125-25-316166.md) | [3.1 d](/filings/0001193125-26-115660.md) | [3.8](/filings/0001193125-26-255525.md) | [2.1 d](/filings/0001193125-26-386417.md) |
| Share repurchases | $m | [4.0 d](/filings/0000950170-24-130111.md) | [9.7 d](/filings/0001193125-26-115660.md) | [0.2](/filings/0000950170-25-078693.md) | [0.0 d](/filings/0001193125-25-189456.md) | [10.2 d](/filings/0001193125-25-316166.md) | [3.3 d](/filings/0001193125-26-115660.md) | [0.0](/filings/0000950170-25-078693.md) | [0.0 d](/filings/0001193125-25-189456.md) | [0.0 d](/filings/0001193125-25-316166.md) | [0.0 d](/filings/0001193125-26-115660.md) | not reported | not reported |

- Operating cash flow: us-gaap:NetCashProvidedByUsedInOperatingActivities
- Capital expenditure: us-gaap:PaymentsToAcquirePropertyPlantAndEquipment
- Share repurchases: us-gaap:PaymentsForRepurchaseOfCommonStock

## Shares

| Line item | Unit | Q3 FY2022 (2022-10-29) | Q1 FY2023 (2023-04-29) | Q2 FY2023 (2023-07-29) | Q3 FY2023 (2023-10-28) | Q1 FY2024 (2024-05-04) | Q2 FY2024 (2024-08-03) | Q3 FY2024 (2024-11-02) | Q1 FY2025 (2025-05-03) | Q2 FY2025 (2025-08-02) | Q3 FY2025 (2025-11-01) | Q1 FY2026 (2026-05-02) | Q2 FY2026 (2026-08-01) |
| --- | --- | ---: | ---: | ---: | ---: | ---: | ---: | ---: | ---: | ---: | ---: | ---: | ---: |
| Diluted shares (weighted) | millions of shares | [66.2](/filings/0000950170-23-064680.md) | [66.3](/filings/0000950170-24-066390.md) | [65.4](/filings/0000950170-24-101685.md) | [63.5](/filings/0000950170-24-130111.md) | [61.0](/filings/0000950170-25-078693.md) | [61.1](/filings/0001193125-25-189456.md) | [57.1](/filings/0001193125-25-316166.md) | [53.6](/filings/0001193125-26-255525.md) | [53.8](/filings/0001193125-26-386417.md) | [54.3](/filings/0001193125-25-316166.md) | [54.9](/filings/0001193125-26-255525.md) | [56.3](/filings/0001193125-26-386417.md) |

- Diluted shares (weighted): us-gaap:WeightedAverageNumberOfDilutedSharesOutstanding

Shares outstanding: 55,453,550 at 2026-09-03, from the cover of the [10-Q filed 2026-09-09](/filings/0001193125-26-386417.md) (dei:EntityCommonStockSharesOutstanding).

Source: SEC EDGAR, XBRL company facts. Last ingested by Listed: Oct 24, 2026, 15:25 ET. No prices; not investment advice.